People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Raptor Pharmaceutical Corp | — | Pharmaceuticals | Series B | $15.1M | $512.1M | 2010 |
Richard L. Franklin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard L. Franklin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher M. Starr | 1 | 3 |
| Raymond W. Anderson | 1 | 3 |
| Kim R. Tsuchimoto | 1 | 2 |
| Todd C. Zankel | 1 | 2 |
| Erich W. Sager | 1 | 1 |
| Patrice P. Rioux | 1 | 1 |
| Llew L. Keltner | 1 | 1 |
| Thomas E. Daley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.